Has United Therapeutics Corporation's (NASDAQ:UTHR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
yahoo.com
news
2022-05-29 14:58:46

Most readers would already be aware that United Therapeutics' (NASDAQ:UTHR) stock increased significantly by 40% over the past three months. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided to study its financial indicators more closely to see if they had a hand to play in the recent price move. In this article, we decided to focus on United Therapeutics' ROE.

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital.
